Improvement of hemostasis in open and laparoscopically performed partial nephrectomy using a gelatin matrix-thrombin tissue sealant (FloSeal)

被引:103
作者
Richter, F [1 ]
Schnorr, D [1 ]
Deger, S [1 ]
Türk, I [1 ]
Roigas, J [1 ]
Wille, A [1 ]
Loening, SA [1 ]
机构
[1] Humboldt Univ, Charite, Klin & Poliklin Urol, D-10117 Berlin, Germany
关键词
D O I
10.1016/S0090-4295(02)02143-X
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives. Long-term follow-up studies have demonstrated that effective local tumor control and longterm tumor-free progression rates can be achieved by nephron-sparing surgery. However, hemostasis is a maj. or issue, and the lack of effective means of hemostasis has limited the wider use of the laparoscopic approach to nephron-sparing surgery. Methods. Between January 2001 and April 2002, 25 patients with renal cell carcinoma were treated with partial nephrectomy using a two-component tissue sealant (FloSeal). The median age was 54 years (range 42 to 71). The follow-up time was 1 to 12 months (median 3.5). The tumor diameter ranged from 2 to 5 cm (median 2.8). Fifteen cases were performed by open retroperitoneal surgery, and 10 cases were performed laparoscopically. The two-component tissue sealant (consisting of a gelatin matrix granula component and a thrombin component) was applied after resection of the tumor and before perfusion of the kidney. The following parameters were recorded: time until complete hemostasis was achieved; decrease in postoperative hemoglobin level; postoperative bleeding; and presence or absence of a perirenal hematoma 24 hours and 10 days postoperatively by ultrasonography. Results. After application of the tissue sealant for 1 to 2 minutes to the moist resection site, hemostasis was immediate in all cases. During the laparoscopically performed partial nephrectomies, a laparoscopic applicator was used to avoid wasting the tissue sealant within the dead space of the instrument. When reperfusion of the kidney was established, hemostasis was maintained. The decrease in postoperative hemoglobin level ranged from 0.3 to 1.2 points (median 0.7). None of the patients required blood transfusions. No postoperative bleeding occurred. The ultrasound examination 24 hours and 10 days postoperatively demonstrated the absence of a significant perirenal hernatoma. Conclusions. The two-component tissue sealant RoSeal provided immediate and durable hemostasis in open and laparoscopically performed partial nephrectomies. The tissue sealant may provide a tool to expand the possibilities of laparoscopic nephron-sparing surgery. UROLOGY 61: 73-77, 2003. (C) 2003, Elsevier Science Inc.
引用
收藏
页码:73 / 77
页数:5
相关论文
共 13 条
[1]   Does the absorbable fibrin adhesive bandage facilitate partial nephrectomy? [J].
Cornum, RL ;
Morey, AF ;
Harris, R ;
Gresham, V ;
Daniels, R ;
Knight, RW ;
Beall, D ;
Pusateri, A ;
Holcomb, J ;
MacPhee, M .
JOURNAL OF UROLOGY, 2000, 164 (03) :864-867
[2]  
HOOD DB, 1999, 24 WORLD C INT SOC C
[3]   Becoming Caucasian: Vicissitudes of whiteness in American politics and culture [J].
Jacobson, MF .
IDENTITIES-GLOBAL STUDIES IN CULTURE AND POWER, 2001, 8 (01) :83-104
[4]   Laparoscopic nephron sparing surgery for small renal cell carcinoma [J].
Janetschek, G ;
Daffner, P ;
Peschel, R ;
Bartsch, G .
JOURNAL OF UROLOGY, 1998, 159 (04) :1152-1155
[5]   Laparoscopic nephron-sparing surgery for renal tumors [J].
Jeschke, K ;
Peschel, R ;
Wakonig, J ;
Schellander, L ;
Bartsch, G ;
Henning, K .
UROLOGY, 2001, 58 (05) :688-692
[6]   FIBRIN GLUE IN RENAL AND URETERAL TRAUMA [J].
KRAM, HB ;
OCAMPO, HP ;
YAMAGUCHI, MP ;
NATHAN, RC ;
SHOEMAKER, WC .
UROLOGY, 1989, 33 (03) :215-218
[7]  
LEVINSON AK, 1991, UROLOGY, V38, P314
[8]   Controlled clinical trial of a novel hemostatic agent in cardiac surgery [J].
Oz, MC ;
Cosgrove, DM ;
Badduke, BR ;
Hill, JD ;
Flannery, MR ;
Palumbo, R ;
Topic, N .
ANNALS OF THORACIC SURGERY, 2000, 69 (05) :1376-1382
[9]   A multicenter, prospective, randomized trial evaluating a new hemostatic agent for spinal surgery [J].
Renkens, KL ;
Payner, TD ;
Leipzig, TJ ;
Feuer, H ;
Morone, MA ;
Koers, JM ;
Lawson, KJ ;
Lentz, R ;
Shuey, H ;
Conaway, GL ;
Andersson, GBJ ;
An, HS ;
Hickey, M ;
Rondinone, JF ;
Shargill, NS .
SPINE, 2001, 26 (15) :1645-1650
[10]   FloSeal®:: A new hemostyptic agent in peripheral vascular surgery [J].
Reuthebuch, O ;
Lachat, ML ;
Vogt, P ;
Schurr, U ;
Turina, M .
VASA-JOURNAL OF VASCULAR DISEASES, 2000, 29 (03) :204-206